References
-
Abel K, Algeria-Hartman MJ, Rothaeusler K, Marthas M, Miller CJ (2002). The relationship between Simian Immunodeficiency virus RNA levels and the mRNA levels of Alpha/Beta Interferon (IFN
${\alpha}/{\beta}$ ) and IFN${\alpha}/{\beta}$ -inducible MX in Lymphoid tissue of Rhesus Macaques during Acute and Chronic infection. J Virol, 76, 8433-45. https://doi.org/10.1128/JVI.76.16.8433-8445.2002 - Aline Gonzalez Vigani, Eduardo Sellan Goncales, Maria Helena Postal Pavan, et al (2012). Therapeutic effectiveness of biosimilar standard interferon versus pegylated interferon for chronic hepatitis C genotypes 2 or 3. Braz J Infect Dis, 16, 232-6. https://doi.org/10.1016/S1413-8670(12)70316-1
- AASLD (American Association for the Study of Liver Diseases). Recommendations for testing, managing and treating hepatitis C. Monitoring patients who are starting hepatitis C treatment, are on treatment, or have completed therapy http://www.hcvguidelines.org/full-report/monitoring-patientswho-are-starting-hepatitis-c-treatment-are-treatment-orhave
- Baglioni C, Nilsen TW (1984). in Gresser 1 (ed) Interferon. Vol.5. Academic Press. New York p23; 1984.
- Blanchard A, Helene D'Iorio and Robert Ford (2010). What you need to know to succeed: Key trends in Canada's biotech industry. Insights, spring.
- Doris Muller-Doblies, Mathias Ackermann and Alfred Metzler (2002). In vitro and in vivo detection of mx gene products in bovine cells following stimulation with alpha/beta interferon and viruses. Clinical Vaccine Immunol, 9, 1192-9. https://doi.org/10.1128/CDLI.9.6.1192-1199.2002
- de Weerd NA, Samarajiwa SA and Hertzog PJ (2007). Type I interferon receptors: biochemistry and biological functions. J Biol Chem, 282, 20053-7. https://doi.org/10.1074/jbc.R700006200
- EMEA (2006). Guideline on similar biological medicinal products containing biotecnology-derived proteins as active substance: QUALITY ISSUES.
- EMEA (2008). D.R.E.R., Questions and answers on biosimilar medicines (similar biological medicinal products). London.
- Entrez Gene (2013). MX1 myxovirus (influenza virus) resistance 1, interferon-inducible protein p78 (mouse).
- EASL (European Association for the Study of the Liver) (2014). Clinical practice guidelines: management of hepatitis C virus infection. J Hepatol, 60, 392-420. https://doi.org/10.1016/j.jhep.2013.11.003
- Ge D, Fellay J, Thompson AJ, et al (2009). Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature, 461, 399-401. https://doi.org/10.1038/nature08309
- Gao J, Xie L, Yang WS, et al (2012). Risk factors of hepatocellular carcinoma--current status and perspectives. Asian Pac J Cancer Prev, 13, 743-52. https://doi.org/10.7314/APJCP.2012.13.3.743
- Horisberger MA (1992). Interferon-induced human protein MxA is a GTPase which binds transiently to cellular proteins. J Virol, 66, 4705-9.
- Haller O, Staeheli P, Kochs G (2007). Interferon-induced Mx proteins in antiviral host defense. Biochimie, 89, 812-8. https://doi.org/10.1016/j.biochi.2007.04.015
- Hideaki Tsukuma, Hideo Tanaka, Wakiko Ajiki, Akira Oshima (2005). Liver cancer and its prevention. Asian Pac J Cancer Prev, 6, 244-50.
- James G. Files, Julia L. Gray, Linh T. Do, et al (1998). A novel sensitive and selective bioassay for human type i interferons. J Interferon Cytokine Res, 18, 1019-24. https://doi.org/10.1089/jir.1998.18.1019
- Lund JM1, Alexopoulou L, Sato A, et al (2004). Recognition of single-stranded RNA viruses by Toll-like receptor 7. Proc Natl Acad Sci U S A, 101, 5598-603. https://doi.org/10.1073/pnas.0400937101
- KD Croen (1993). Evidence for antiviral effect of nitric oxide. Inhibition of herpes simplex virus type 1 replication. J Clin Invest, 91, 2446-52. https://doi.org/10.1172/JCI116479
- Korth M.J, Taylor M.D, Katze M.G (1998). Interferon inhibits the replication of HIV-1, SIV and SHIV chimeric viruses by distinct mechanisms. Virology, 247, 265-73. https://doi.org/10.1006/viro.1998.9249
- Kenneth C.M, Worthen S (2003). Lipopolysaccharide stimulates p38-dependent induction of antiviral genes in neutrophils independently of paracrine factors. J Biol Chem, 278, 15693-701. https://doi.org/10.1074/jbc.M212033200
- Manns MP, McHutchison JG, Gordon SC, et al (2001). Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C. Randomised trial. Lancet, 358, 958-65. https://doi.org/10.1016/S0140-6736(01)06102-5
- Mohamed A.F, Shoman S.A (2006). Antiviral activity of recombinant human interferon-α to rift valley fever virus and related Mx-protein potential as a biomarker. Egy J Biotechnol, 21, 203-6.
- Mehta DR, Ashkar AA, Mossman KL (2012). The nitric oxide pathway provides innate antiviral protection in conjunction with the type i interferon pathway in fibroblasts. PLoS ONE, 7, 31688. https://doi.org/10.1371/journal.pone.0031688
- Nick C (2012). The US biosimilars act: challenges facing regulatory approval. Pharm Med, 26, 2145-52.
- Pavlovic J, Haller O, Staeheli P (1992). Human and mouse Mx proteins inhibit different steps of the influenza virus multiplication cycle. J Virol, 66, 2564-9.
- Ponten A, Sick C, Weeber M, Haller O, Kochs G (1997). Dominant-negative mutants of human MXA protein: domains in the carboxy-terminal moiety are important for oligomerization and antiviral activity. J Virol, 71, 2591- 9.
- Parkin DM, Bray F, Ferlay J, Pisani P (2001). Estimating the world cancer burden: Globocan 2000. Int J Cancer, 94, 153-6. https://doi.org/10.1002/ijc.1440
- Reed LJ, Muench H (1938). A simple method of estimating fifty percent end-points. Am J Hygiene, 27, 493-7.
- Sambrook J, Fritch E.F, Maniatis T (1989). Molecular cloning: A Laboratory Manual Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
- Shinji H (2005). The broad anti-viral agent glycyrrhizin directly modulates the fluidity of plasma membrane and HIV-1 envelope. Biochem J antiviral, 392, 191-9.
- Steven S, Richard LH, Stephen AY, Weidbrauk DL (2009). Clinical virology manual, 4th ed, ASM press, pp 1-692.
- Sahapat Barusrux, Chatchawan Sengthong, Yupa Urwijitaroon (2014). Epidemiology of hepatitis C virus genotypes in northeastern Thai blood samples. Asian Pac J Cancer Prev, 15, 8837-42 https://doi.org/10.7314/APJCP.2014.15.20.8837
- Samir Y Abbas, Awatef A Farag, Yousry A, Ammar, et al (2013). Synthesis, characterization, and antiviral activity of novel fluorinated isatin derivatives. Monatsh Chem, 144, 1725-33. https://doi.org/10.1007/s00706-013-1034-3
- World Health Organization (2009). Expert committee on biological standardization: guidelines on evaluation of similar biotherapeutic products (SBPs). World Health Organization. http://www.who.int/biologicals/areas/biological_therapeutics/BIOTHERAPEUTICS_FOR_WEB_22APRIL2010.pdf http://www.who.int/biologicals/publications/trs/areas/biological_therapeutics/TRS_977_Annex_2.pdf?ua=1
- Xiao-Chun Ni, Yong Yi, Yi-Peng Fu, et al (2014). Serum Amyloid A is a Novel Prognostic Biomarker in Hepatocellular Carcinoma. Asian Pac J Cancer Prev, 15, 10713-8.